Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Risk factors for convertion to clinically defined multiple sclerosis after clinically isolated syndrome in a racially mixed Brazilian cohort.
Women's Issues in Multiple Sclerosis.
Susceptibility tensor imaging (STI) of the brain.
The effects of prolonged wear of textured shoe insoles on gait, foot sensation and proprioception in people with multiple sclerosis: study protocol for a randomised controlled trial.
Neurological involvement in Primary Sjögren Syndrome.
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells.
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Reassessing the risk of natalizumab-associated PML.
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Effects of dimethyl fumarate on lymphocyte subsets.
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
Optical Coherence Tomography: A Potential Noninvasive Follow-up Tool in Multiple Sclerosis.
Evaluation of quality of life and fatigue in radiologically isolated syndrome.
Population pharmacokinetics of ponesimod and its primary metabolites in healthy and organ-impaired subjects.
Dimethyl fumarate protection against collagen II degradation.
Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response.
Glatiramer acetate induced hepatotoxicity.
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
Diagnosis and treatment of hyponatraemia.
Policy: NIH to balance sex in cell and animal studies.
Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies.
Evidence for Mitoxantrone-induced Block of Inwardly Rectifying K Channels Expressed in the Osteoclast Precursor RAW 264.7 Cells Differentiated with Lipopolysaccharide.

Pages